(Q79380868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Moses Rodriguez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Chella David

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

3356-3370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

Assembly, transport, and function of MHC class II molecules

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

HLA disease associations: models for the study of complex human genetic disorders

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Genetic susceptibility to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Genes in the spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Genetics of type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

A review of the MHC genetics of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Genetic analysis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

HLA class II transgenic mice as models of human diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Genetics of multiple sclerosis: linkage and association studies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Activated human T cells can present denatured antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Increased MHC class II and CD25 expression on lymphocytes in the absence of persistent lymphocytosis in cattle experimentally infected with bovine leukemia virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Anti-alpha chain monoclonal antibodies of equine MHC class-II antigens: applications to equine infectious anaemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Canine MHC-class II antigens on B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Expression of major histocompatibility complex class II molecules in rat T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Immune response to staphylococcal superantigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

V beta-specific stimulation of human T cells by staphylococcal toxins.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

CIITA activates the expression of MHC class II genes in mouse T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Genetic control of MHC class II expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

TCR-Mediated internalization of peptide-MHC complexes acquired by T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Professional presentation of antigen by activated human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Early signaling defects in human T cells anergized by T cell presentation of autoantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

T cells as antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Transforming growth factor-beta induces development of the T(H)17 lineage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Mice lacking all conventional MHC class II genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636217

7 January 2021

Identifiers

DOI

10.1002/EJI.200636217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17125142%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference